Search research articles
Contact Us
Filters
Showing results (21-30 of 53) with videos related to
Page
of 6
Sort By:
Hormones (Athens, Greece)
|
June 30, 2006
Estradiol and progesterone supplementation during luteal phase improved the receptivity of the endometrium in a patient with a history of diethylstilboestrol exposure in-utero
Dimitris Loutradis, Konstantinos Stefanidis, Erasmia Kiapekou, et al.
Journal of Perinatal Medicine
|
October 22, 2017
Safety and efficacy of the cervical pessary combined with vaginal progesterone for the prevention of spontaneous preterm birth
Georgios Daskalakis, Dimitrios Zacharakis, Marianna Theodora, et al.
Hormone Molecular Biology and Clinical Investigation
|
July 1, 2022
Association between <i>TP53</i> Arg72Pro variant and recurrent pregnancy loss in the Greek population
Dimitra Dedousi, Despoina Mavrogianni, Myrto Papamentzelopoulou, et al.
Journal of Perinatal Medicine
|
April 20, 2018
Reply to: Cervical pessary combined with vaginal progesterone for the prevention of spontaneous preterm birth: is evidence sufficient?
Georgios Daskalakis, Dimitrios Zacharakis, Marianna Theodora, et al.
Journal of Assisted Reproduction and Genetics
|
March 16, 2013
Do estrogen receptor alpha polymorphisms have any impact on the outcome in an ART program?
Elli Anagnostou, Fotodotis Malamas, Despina Mavrogianni, et al.
Journal of Assisted Reproduction and Genetics
|
June 8, 2006
FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs
Dimitris Loutradis, Eleni Patsoula, Vassilis Minas, et al.
Gynecologic Oncology Reports
|
April 29, 2021
Menstural function preservation treatment of a primary vaginal clear cell carcinoma with ovarian transposition and vaginal brachytherapy
Dimitrios-Efthymios Vlachos, Athanasios Protopapas, Georgios Vlachos, et al.
Cancer Genetics
|
August 27, 2019
Prevalence and founder effect of the BRCA1 p.(Val1833Met) variant in the Greek population, with further evidence for pathogenicity and risk modification
Myrto Papamentzelopoulou, Paraskevi Apostolou, Florentia Fostira, et al.
Current Pharmaceutical Biotechnology
|
October 30, 2020
Individual and Combined Assessment of Ser680Asn FSH Receptor and FSHβ-211 G>T Gene Polymorphisms in Ovarian Response in IVF/ICSI Program
Elli Anagnostou, Alexia Kafkoutsou, Despina Mavrogianni, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
March 31, 2019
Intraoperative local infiltration with ropivacaine 0.5% in women undergoing vaginal hysterectomy and pelvic floor repair: Randomized double-blind placebo-controlled trial
Stavros Athanasiou, Sophia Hadzillia, Eleni Pitsouni, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 53) with videos related to
Sort By:
Page
of 6
Hormones (Athens, Greece)
|
June 30, 2006
Estradiol and progesterone supplementation during luteal phase improved the receptivity of the endometrium in a patient with a history of diethylstilboestrol exposure in-utero
Dimitris Loutradis, Konstantinos Stefanidis, Erasmia Kiapekou, et al.
Journal of Perinatal Medicine
|
October 22, 2017
Safety and efficacy of the cervical pessary combined with vaginal progesterone for the prevention of spontaneous preterm birth
Georgios Daskalakis, Dimitrios Zacharakis, Marianna Theodora, et al.
Hormone Molecular Biology and Clinical Investigation
|
July 1, 2022
Association between <i>TP53</i> Arg72Pro variant and recurrent pregnancy loss in the Greek population
Dimitra Dedousi, Despoina Mavrogianni, Myrto Papamentzelopoulou, et al.
Journal of Perinatal Medicine
|
April 20, 2018
Reply to: Cervical pessary combined with vaginal progesterone for the prevention of spontaneous preterm birth: is evidence sufficient?
Georgios Daskalakis, Dimitrios Zacharakis, Marianna Theodora, et al.
Journal of Assisted Reproduction and Genetics
|
March 16, 2013
Do estrogen receptor alpha polymorphisms have any impact on the outcome in an ART program?
Elli Anagnostou, Fotodotis Malamas, Despina Mavrogianni, et al.
Journal of Assisted Reproduction and Genetics
|
June 8, 2006
FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs
Dimitris Loutradis, Eleni Patsoula, Vassilis Minas, et al.
Gynecologic Oncology Reports
|
April 29, 2021
Menstural function preservation treatment of a primary vaginal clear cell carcinoma with ovarian transposition and vaginal brachytherapy
Dimitrios-Efthymios Vlachos, Athanasios Protopapas, Georgios Vlachos, et al.
Cancer Genetics
|
August 27, 2019
Prevalence and founder effect of the BRCA1 p.(Val1833Met) variant in the Greek population, with further evidence for pathogenicity and risk modification
Myrto Papamentzelopoulou, Paraskevi Apostolou, Florentia Fostira, et al.
Current Pharmaceutical Biotechnology
|
October 30, 2020
Individual and Combined Assessment of Ser680Asn FSH Receptor and FSHβ-211 G>T Gene Polymorphisms in Ovarian Response in IVF/ICSI Program
Elli Anagnostou, Alexia Kafkoutsou, Despina Mavrogianni, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
March 31, 2019
Intraoperative local infiltration with ropivacaine 0.5% in women undergoing vaginal hysterectomy and pelvic floor repair: Randomized double-blind placebo-controlled trial
Stavros Athanasiou, Sophia Hadzillia, Eleni Pitsouni, et al.
Page
of 6